The board of directors guiding Nyxoah comprises experienced medical technology executives, life science entrepreneurs, and independent governance experts. Key members include founder and Chairman Robert Taub, alongside independent directors Kevin Rakin, Dr. Jürgen Hambrecht, Rita Johnson-Mills, and Virginia Kirby, who collectively provide strategic oversight across clinical research, global regulatory compliance, and commercialization strategies.